These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19564815)

  • 1. Protection of intestinal permeability in the perioperative period.
    Theodorou D; Aggeli P; Markogiannakis H; Skouroliakou M; Archontovasilis F; Kastanidou O; Burnetas A; Xiromeritou V; Katsaragakis S
    J Clin Gastroenterol; 2009; 43(5):500. PubMed ID: 19564815
    [No Abstract]   [Full Text] [Related]  

  • 2. Intestinal bacterial microflora--a potential source of chronic inflammation in patients with chronic kidney disease.
    Kotanko P; Carter M; Levin NW
    Nephrol Dial Transplant; 2006 Aug; 21(8):2057-60. PubMed ID: 16762961
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacterial translocation in surgical patients.
    MacFie J
    Ann R Coll Surg Engl; 1997 May; 79(3):183-9. PubMed ID: 9196338
    [No Abstract]   [Full Text] [Related]  

  • 4. Prokinetics reduce bacterial translocation in cirrhosis: will sweeping the gut keep the fluid clean?
    García-Tsao G
    Gastroenterology; 2001 Jan; 120(1):314-6. PubMed ID: 11208746
    [No Abstract]   [Full Text] [Related]  

  • 5. Mucosal permeability and mast cells as targets for functional gastrointestinal disorders.
    Keita ÅV; Söderholm JD
    Curr Opin Pharmacol; 2018 Dec; 43():66-71. PubMed ID: 30216901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of probiotics on intestinal barrier function.
    Mennigen R; Bruewer M
    Ann N Y Acad Sci; 2009 May; 1165():183-9. PubMed ID: 19538305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal flora, probiotics, and cirrhosis.
    Guerrero Hernández I; Torre Delgadillo A; Vargas Vorackova F; Uribe M
    Ann Hepatol; 2008; 7(2):120-4. PubMed ID: 18626428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease.
    Lewis CV; Taylor WR
    Am J Physiol Heart Circ Physiol; 2020 Dec; 319(6):H1227-H1233. PubMed ID: 32986965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics, breastfeeding and atopic eczema.
    Michaelsen KF
    Acta Derm Venereol Suppl (Stockh); 2005 Nov; (215):21-4. PubMed ID: 16321903
    [No Abstract]   [Full Text] [Related]  

  • 10. Probiotics in surgery.
    van Santvoort HC; Besselink MG; Timmerman HM; van Minnen LP; Akkermans LM; Gooszen HG
    Surgery; 2008 Jan; 143(1):1-7. PubMed ID: 18154927
    [No Abstract]   [Full Text] [Related]  

  • 11. Probiotic carbohydrates reduce intestinal permeability and inflammation in metabolic diseases.
    Strowski MZ; Wiedenmann B
    Gut; 2009 Aug; 58(8):1044-5. PubMed ID: 19592687
    [No Abstract]   [Full Text] [Related]  

  • 12. [Substantiation of enterosane application for the treatment of celiac disease].
    Bogdarin IuA; Repin AA
    Eksp Klin Gastroenterol; 2004; (4):36-8. PubMed ID: 15568666
    [No Abstract]   [Full Text] [Related]  

  • 13. [Irritable bowel syndrome: issues of diagnosis and treatment efficiency].
    Loranskaia ID
    Eksp Klin Gastroenterol; 2008; (1):90-5. PubMed ID: 19145859
    [No Abstract]   [Full Text] [Related]  

  • 14. Infant formula oligosaccharides opening the gates (for speculation): commentary on the article by Barrat et al. on page 34.
    Ninonuevo MR; Bode L
    Pediatr Res; 2008 Jul; 64(1):8-10. PubMed ID: 18574406
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of intestinal side-effects of antibiotics with Perenterol].
    Donat F
    Munch Med Wochenschr; 1970 Jan; 112(2):74-7. PubMed ID: 5467104
    [No Abstract]   [Full Text] [Related]  

  • 16. Probiotics in cirrhosis: do we expect too much?
    Soriano G; Guarner C
    Liver Int; 2013 Nov; 33(10):1451-3. PubMed ID: 24099262
    [No Abstract]   [Full Text] [Related]  

  • 17. [Strategies for the eutrophic treatment and management of the diarrheic patient: dietetic fiber and probiotics].
    López González MC
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():88-9. PubMed ID: 17471872
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of probiotic bacteria in sepsis.
    Fujita T
    Hepatology; 2008 Apr; 47(4):1422; author reply 1422-3. PubMed ID: 18366113
    [No Abstract]   [Full Text] [Related]  

  • 19. [Investigation of dysbiosis developing during "dry" immersion and methods of correction].
    Il'in VK; Kriukov AI; Volozhin AI; Istranov LP; Istranova EV; Kiriukhina NV; Starkova LV; Morozova IuA; Usanova NA
    Aviakosm Ekolog Med; 2008; 42(5):70-4. PubMed ID: 19192543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotic microbes: do they need to be alive to be beneficial?
    Kataria J; Li N; Wynn JL; Neu J
    Nutr Rev; 2009 Sep; 67(9):546-50. PubMed ID: 19703261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.